You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

NALBUPHINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nalbuphine Hydrochloride, and when can generic versions of Nalbuphine Hydrochloride launch?

Nalbuphine Hydrochloride is a drug marketed by Abbott, Abbvie, Dr Reddys, Hospira, Igi Labs Inc, and Rising. and is included in fifteen NDAs.

The generic ingredient in NALBUPHINE HYDROCHLORIDE is nalbuphine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nalbuphine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nalbuphine Hydrochloride

A generic version of NALBUPHINE HYDROCHLORIDE was approved as nalbuphine hydrochloride by HOSPIRA on February 3rd, 1989.

  Try a Trial

Drug patent expirations by year for NALBUPHINE HYDROCHLORIDE
Recent Clinical Trials for NALBUPHINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityEarly Phase 1
Sinew Pharma Inc.Phase 2
Li-Jen HsinPhase 4

See all NALBUPHINE HYDROCHLORIDE clinical trials

Pharmacology for NALBUPHINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for NALBUPHINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for NALBUPHINE HYDROCHLORIDE

US Patents and Regulatory Information for NALBUPHINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070917-001 Feb 3, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rising NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 207595-002 Jan 11, 2019 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070916-001 Feb 3, 1989 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 074471-002 Mar 19, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Igi Labs Inc NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 072073-001 Apr 10, 1989 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 070918-001 Feb 3, 1989 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rising NALBUPHINE HYDROCHLORIDE nalbuphine hydrochloride INJECTABLE;INJECTION 207595-001 Jan 11, 2019 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.